GM1 Ganglioside: Epilepsy, Stroke, TBI, & Autism Treatment (5 x 2ml Vials)

Title: Monossial Ganglioside GM1 for Epilepsy, Stroke, Brain Trauma, and Autism (5 x 2ml Ampoules)

Description:

Monossial ganglioside GM1 is a naturally occurring component of nerve cell membranes. This supplement supports nerve cell regeneration and repair, offering potential benefits for individuals recovering from neurological challenges. It’s shown to promote axonal growth, synapse formation, and improved neuronal survival, potentially aiding in the recovery from stroke, brain trauma, epilepsy, and autism. Each pack contains 5 x 2ml ampoules. Not a drug.

Benefits and Mechanisms of Action:

Monossial ganglioside GM1 works by increasing the concentration of naturally occurring gangliosides in the body. This process promotes:

• Nerve Regeneration: Stimulates the growth of axons (the long fibers that transmit nerve impulses) and synapses (connections between nerve cells).
• Neural Repair: Helps rebuild damaged neural pathways and connections lost due to injury or disease.
• Improved Neuronal Survival: Enhances the viability and longevity of nerve cells.
• Reduced Neuronal Swelling: Minimizes inflammation and swelling in brain tissue.
• Enhanced Enzyme Activity: Improves the function of enzymes within cell membranes crucial for nerve health.

Indications:

Monossial ganglioside GM1 is indicated as a supportive therapy for a variety of central nervous system (CNS) disorders, particularly in the rehabilitation period following injury or illness. Specific applications include:

• Stroke Rehabilitation
• Parkinson’s Disease
• Epilepsy
• Autism
• Optic Nerve Atrophy
• Congenital CNS Malformations in Children

Dosage and Administration:

Dosage should be determined by a healthcare professional. However, general guidelines include:

• Typical Dosage: 20-40 mg daily administered either intravenously or intramuscularly.
• Acute Conditions: Intravenous administration of 100 mg daily for 2-3 weeks, followed by 20-40 mg daily for another 2-3 weeks. Total treatment duration is typically 6 weeks.
• Parkinson’s Disease: Initial intravenous dose of 500-1000 mg, followed by 200 mg daily (intravenously or intramuscularly) for up to 18 weeks.

Important Note: Monossial ganglioside GM1 is a supplement and not a substitute for medical treatment. Always consult with a healthcare professional before starting any new supplement, especially if you have pre-existing health conditions or are taking other medications. They can help determine the appropriate dosage and ensure its safe and effective use.